The Industry is expected to reach USD 5.34 billion by 2020 from USD 4.03 billion in 2015, growing at a CAGR of 5.80% during the forecast period 2015-2020.
- Advertising -
According to the report North America Insulin Delivery Devices Industry, published by Market Data Forecast,
Insulin maintains sugar levels in the blood and essential for the people suffering from type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged from the past years.
These devices are used to deliver the insulin doses via parenteral route rather than oral route of administration.
- Advertising -
Insulin delivery devices promote absorption rate of insulin into blood stream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.
Browse Market data tables and in-depth TOC of the North America Insulin Delivery Devices Industry to 2020 @ www.marketdataforecast.com/market-…vices-market-259/
Growing number of obese population, increasing healthcare expenditure, rising number of diabetes patients, availability of medical reimbursements for human insulin pens in the U.S., and presence of more number of Industry players are driving the growth of insulin delivery devices Industry in North America. However, stringent regulatory laws for the product approval and low penetration rate of advanced insulin delivery devices in this region are restraining the growth of insulin delivery devices Industry in North America.
North America insulin delivery devices Industry is segmented based on the type and application. Based on type, the Industry is further sub-segmented as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.
Of these, insulin syringes commanded the largest share of North America insulin delivery devices Industry in 2015, whereas insulin pens segment is estimated to grow at the highest CAGR during the forecast period 2015-2020. Based on application, the Industry is segmented as type I diabetes and type II diabetes.
Free sample of the report is available @ www.marketdataforecast.com/market-…59/request-sample
On the basis of geographical areas, North America insulin delivery devices Industry is segmented as U.S., and Canada. U.S., accounted for larger share of the North America insulin delivery devices Industry in 2015, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2015-2020.
The key players in insulin delivery devices Industry such as, Becton, Dickinson and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd.
(India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.).
Inquire about report @ www.marketdataforecast.com/market-…arket-259/inquire
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
North America Insulin Delivery Devices Industry: Segmentation
- o Insulin Syringes
- o Insulin Pens
- o Insulin Pen Needles
- o Insulin Pumps
- o Insulin Jet Injectors
- o Type I Diabetes
- o Type II Diabetes
- United States
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Access report @ www.marketdataforecast.com/market-…/request-discount
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: